Morgan Stanley Anebulo Pharmaceuticals, Inc. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 399,219 shares of ANEB stock, worth $646,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
399,219
Previous 399,219
-0.0%
Holding current value
$646,734
Previous $1.09 Million
29.29%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.34MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$8.69 Million11.7% of portfolio
-
Lvw Advisors, LLC641KShares$1.04 Million0.16% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$827,9380.06% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$255,7360.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA154KShares$249,5380.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $41.5M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...